Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials

Christopher E.M. Griffiths*, Kristian Reich, Mark Lebwohl, Peter Van De Kerkhof, Carle Paul, Alan Menter, Gregory S. Cameron, Janelle Erickson, Lu Zhang, Roberta J. Secrest, Susan Ball, Daniel K. Braun, Olawale O. Osuntokun, Michael P. Heffernan, Brian J. Nickoloff, Kim Papp, Diamant Thaci

*Corresponding author for this work
280 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): Results from two phase 3 randomised trials'. Together they form a unique fingerprint.

Nursing and Health Professions

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology